MASTERCLASS: 5 Mistakes with Fenben, Meben, & Ivermectin

Fenbendazole vs Mebendazole vs Ivermectin: Cancer

 

Three Antiparasitic Worm Medicines Scientists Are Studying for Cancer

Researched and Written by Keith Bishop, Clinical Nutritionist, Cancer Coach, Retired Pharmacist, Integrative Oncology Educator

You may have heard people talk about three medicines: fenbendazole, mebendazole, and ivermectin. All three were made to kill parasitic worms or bugs, not cancer. But scientists are now studying them to see if they can also fight cancer cells.

These three medicines are not the same. They work in different ways. This article explains what each one does, how they are alike, and how they are different — using easy words and short sentences.

This article will not tell you to take these drugs. It also won't tell you to avoid them. It just explains what scientists have found so far, in plain language.

What Do All Three Have in Common?

Fenbendazole and mebendazole come from the same drug family. They are both called "benzimidazoles," which is just a fancy word for a type of dewormer.

Iver

...
Continue Reading...

Fenbendazole, Ivermectin & p53: Anticancer Research

Fenbendazole and Ivermectin in Cancer Care: What the Research Actually Shows

A clinical nutritionist's review of mechanisms — including p53 reactivation, microtubule disruption, glycolysis inhibition, and immune synergy — for two of the most-discussed repurposed antiparasitics in integrative oncology.

Researched and written by Keith Bishop, Integrative Cancer Educator, Cancer Coach, Clinical Nutritionist, Retired Pharmacist, and Founder of Prevail Over Cancer.

You've heard the names. A friend mentioned them. A YouTube video swore by them. A Facebook group of 100,000 members says they cured stage IV cancer. And your oncologist either rolled their eyes or warned you against them.

So what is actually true about fenbendazole and ivermectin in cancer care?

After three decades as a pharmacist and now as a clinical nutritionist and cancer coach working with patients every day, I want to walk you through what the published research actually shows — the mechanisms, the preclinical data, th...

Continue Reading...
Close

Get Free Access to Keith’s Sunday Tactics Newsletter.

Join thousands of subscribers!
Get new cancer tactics each week.